|
|
Documents > food and drug administration
FDADocs 5/5/2008 | 0 (0) | 14 | 0 | 0 | English
Dr. StephenF. Sundlof. Food and Drug Administration Center for Veterinary Medicine 75 19 StandishPlace , Rockville, MD 20855 .,. ’ FDA Docket #: 0 lP-0230 Dear Dr. Sundlof, I am writing to expressmy concern about the possible commercialization of geneti&ly engineered fish. I urge the FDA not to approve the current application by A/F Protein to sell ... more>>
FDADocs 5/5/2008 | 0 (0) | 19 | 0 | 0 | English
Dr. StephenF. ,Sundlof Food and Drug Administration Center for Veterine Medicine 75 19 StandishPlace Rockville, MD 20855 FDA Docket #: OlP-0230 Dear Dr. Sundlof, I am writing. to expressmy concern about the possible commercialization of geneticallyengineered fish. I urge the E’DA not to approve the current application by A/F Protein to sell genetic ... more>>
FDADocs 5/9/2008 | 0 (0) | 22 | 0 | 0 | English
Dr. StephenF. $undlof Food and Drug Administration Center for Veterinary Medicine 75 19 StandishPlace Rockville, MD 20855 FDA Docket #: 0 lP-0230 Dear Dr. Sundlof, I am writing to expressmy concern about the possible commercialization of geneticallyengineeredfish. I urge the FDA not to approve the current application by A@ Protein to sell genetical ... more>>
FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English
December 18,200l
ockets Management Branch Food and Drug Administration EEA-305, Room l-23 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852
,.>i: I rr.^ ,,_. / ,.“/
ii ~ :*
.;,‘“‘ .,. L ,_,/-/, , is .j,cl..
.(’ :, $ .., J ., . *.j.. , ,
Re: Docket 01x)-0361 Comments on Internationals Conference on Harmonisation; Draft guidan Bracketing and Matri ... more>>
FDADocs 5/9/2008 | 0 (0) | 23 | 0 | 0 | English
Food and Drug Administration, HHS
Federal Register, 800 North Capitol St. NW., suite 700, Washington, DC. (3) The reduced minerals whey shall be derived from milk that has been pasteurized, or the reduced minerals whey shall be subjected to pasteurization techniques or its equivalent before use in food. (c) The reduced minerals whey may be used in ... more>>
FDADocs 5/9/2008 | 0 (0) | 22 | 0 | 0 | English
Food and Drug Administration, HHS
Federal Register, 800 North Capitol St. NW., suite 700, Washington, DC. (3) The reduced minerals whey shall be derived from milk that has been pasteurized, or the reduced minerals whey shall be subjected to pasteurization techniques or its equivalent before use in food. (c) The reduced minerals whey may be used in ... more>>
FDADocs 5/12/2008 | 0 (0) | 24 | 0 | 0 | English
Food and Drug Administration, HHS
point of 41 to 43.5 °C, an iodine value of 65 to 69, and a fatty acid composition as follows:
Fatty acid Myristic acid ............................................................. Palmitic acid ............................................................ Palmitoleic acid ........................................... ... more>>
FDADocs 5/9/2008 | 0 (0) | 18 | 0 | 0 | English
WAIS
Document Retrieval
[Federal Register: August-l, 1996 (Volume 61, Number 149)J les and Regulations] age 40153-401553 From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:frOlau96-81
___--_----------------------------------------------------------------___-----------------_____1______I____c__---------------------------- ... more>>
FDADocs 5/5/2008 | 0 (0) | 24 | 0 | 0 | English
November 9,200 1
269
1
'01 NIV 13 P356
Food and Drug Administration 5630 Fishers Lane, Room 106 1 Dockets Management Branch, HFA-305 Rockville, MD 20852 SUBJECT: Draft Guidance entitled, “Guidance for Industry: Biological Product Deviation Reporting for Blood and Plasma Establishments (August 2001),” Docket No. 0 1 D-0220
Dear Sir or Madam: Na ... more>>
FDADocs 5/5/2008 | 0 (0) | 15 | 0 | 0 | English
Dockets Management Branch (HFA-305) Food and Drug Administration Room 1061 5630 Fishers Lane Rockville, Maryland 20852
October 10, 2002
Re: Docket 02P-0177: Health Claim: D-taqatose and Noncarioaenicitv
Dear Sir or Madam, Kellogg is submitting this comment to the Food and Drug Administration (FDA) in support of Arla Foods Ingredients’ (Arla Food ... more>>
FDADocs 5/9/2008 | 0 (0) | 18 | 0 | 0 | English
Food and Drug Administration, HHS
Pt. 341
(c) Warnings. The labeling of the product contains the following warnings under the heading ‘‘Warnings’’: (1) ‘‘The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because to ... more>>
FDADocs 5/12/2008 | 0 (0) | 27 | 0 | 0 | English
Food and Drug Administration, HHS
Pt. 341
(c) Warnings. The labeling of the product contains the following warnings under the heading ‘‘Warnings’’: (1) ‘‘The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because to ... more>>
FDADocs 5/8/2008 | 0 (0) | 10 | 0 | 0 | English
Food and Drug Administration
Crosswalk to All Purpose Table Budget Authority Reallocation Base Effects and Total FY 2004 APT Changes
Dollars in Thousands
Budget Authority Reallocations Budget Authority FY 2004 Effect of Reallocations OCC Reallocation 3/ $000 Foods CFSAN Field Activities Human Drugs CDER Field Activities Biologics CBER Field Ac ... more>>
FDADocs 5/5/2008 | 0 (0) | 16 | 0 | 0 | English
FDADocs 5/5/2008 | 0 (0) | 17 | 0 | 0 | English
April 29,2002
Food and Drug Administration Dockets Management Branch, HRA-305 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Subject: Draft Guidance entitled, “Guidance for Industry: Use of Nucleic Acid Tests on Pooled Samples from Source Plasma Donors to Adequately Reduce the Risk of Transmission of HIV-l and HCV,” Dated December 2001, Docket N ... more>>
| | | |
| results / page 15/25/50 |
Page: 5 of 34
|
5...34
|
|